Smoking Cessation Clinical Trials

The purpose of this research study is to test whether two different treatments can help smokers quit smoking. the first program is only for the smoker, while the other program will involve the smoker and their non-smoking romantic partner. Participants will attend one of the 8-week programs and receive the ...

If you’re taking High Cholesterol medication, you may qualify for a research study. Investigational medication provided at no charge Study-related care from a local doctor at no charge

We are currently recruiting smokers who are really motivated to quit smoking. The purpose of the study is to evaluate the safety and effectiveness of three approved medications, Habitrol, Zyban and Chantix, in combination and compared to a placebo (no active ingredient). Requires 12 weekly visits. Patient Inclusion Criteria: Participants ...

For more information please visit: http://clinicaltrials.gov/ct2/show/NCT01434342?term=CCCWFU+99211&rank=1

Patient Inclusion Criteria: Healthy male & female subjects between the ages of 12 and 19 years, inclusive Subjects must be currently smoking at least an average of 5 cigarettes per day during the past 30 days Subjects must have had at least 1 prior failed attempt to quit smoking Patient ...

Objective 1: To examine the feasibility of conducting an evidence-based, cognitive behavioral therapy (CBT) for tobacco cessation delivered in multiple formats. Participants will have the opportunity to receive a CBT-based tobacco intervention delivered several possible formats (face-to-face, telephone, video-counseling) based on availability and participant preferences. Study participants will be exposed ...

Obesity, smoking and alcohol dependence are major health burdens to society. Relapse after alcohol and smoking abstinence is common despite the use of combined behavioural support and current limited available medications. In obesity, nonsurgical interventions have also been disappointing in achieving longterm weight loss. Therefore, there is a pressing need ...

The overall objective of the transdisciplinary team of Human Immunology Virus (HIV) and Tobacco funded researchers is to test if tailoring nicotine replacement doses to temper these excessive levels will enhance the efficacy of the intervention. This will be accomplished by assessing: 1) pre-trial plasma levels, 2) doing genotyping, which ...

Tobacco smoking is a well-known environmental risk factor for developing rheumatoid arthritis (RA). The onset of RA can occur in all age groups, with the majority being women aged 50-60 years. RA is a chronic inflammatory disease and cannot be cured. However, the activity of the disease can be reduced ...

This will be a randomized, placebo-controlled, parallel-group clinical trial. Nondiabetic, overweight and obese adult smokers will be randomized to one of three arms: lorcaserin for 24 weeks in combination with varenicline for 12 weeks; placebo for 24 weeks in combination with varenicline for 12 weeks; We will assess the following: ...